- Home
- TCRX vs FOSL Comparison
TCRX vs FOSL Comparison
Compare TCRX & FOSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- FOSL
- Stock Information
- Founded
- TCRX 2018
- FOSL 1984
- Country
- TCRX United States
- FOSL United States
- Employees
- TCRX N/A
- FOSL N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- FOSL Consumer Specialties
- Sector
- TCRX Health Care
- FOSL Consumer Discretionary
- Exchange
- TCRX Nasdaq
- FOSL Nasdaq
- Market Cap
- TCRX 140.7M
- FOSL 128.0M
- IPO Year
- TCRX 2021
- FOSL 1993
- Fundamental
- Price
- TCRX $1.89
- FOSL $2.06
- Analyst Decision
- TCRX Strong Buy
- FOSL Strong Buy
- Analyst Count
- TCRX 5
- FOSL 1
- Target Price
- TCRX $9.40
- FOSL $5.00
- AVG Volume (30 Days)
- TCRX 656.4K
- FOSL 1.5M
- Earning Date
- TCRX 11-07-2025
- FOSL 11-05-2025
- Dividend Yield
- TCRX N/A
- FOSL N/A
- EPS Growth
- TCRX N/A
- FOSL N/A
- EPS
- TCRX N/A
- FOSL N/A
- Revenue
- TCRX $6,961,000.00
- FOSL $1,083,797,000.00
- Revenue This Year
- TCRX $255.18
- FOSL N/A
- Revenue Next Year
- TCRX N/A
- FOSL N/A
- P/E Ratio
- TCRX N/A
- FOSL N/A
- Revenue Growth
- TCRX N/A
- FOSL N/A
- 52 Week Low
- TCRX $1.02
- FOSL $0.86
- 52 Week High
- TCRX $6.23
- FOSL $4.40
- Technical
- Relative Strength Index (RSI)
- TCRX 39.56
- FOSL 38.82
- Support Level
- TCRX $1.74
- FOSL $2.01
- Resistance Level
- TCRX $2.43
- FOSL $2.43
- Average True Range (ATR)
- TCRX 0.18
- FOSL 0.27
- MACD
- TCRX -0.07
- FOSL -0.05
- Stochastic Oscillator
- TCRX 14.46
- FOSL 2.09
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About FOSL Fossil Group Inc.
Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.